-
Comparison in prevalence, predictors, and clinical outcome of VSR versus FWR after acute myocardial infarction: The prospective, multicenter registry MOODY trial-heart rupture analysisXue X, Chen SL; MOODY trial investigators. -
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesWriting Committee Members, M Gulati , PD Levy et al.
-
Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non-Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)Choi IJ, Koh YS, Kim PJ et al.
-
Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGJ Vlachojannis , JM Wilschut , RF Vogel et al.
-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialWang TY, Kaltenbach LA, Cannon CP et al.
-
Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload HypertrophyMJ Yang, L Song, L Wang et al.
-
Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACSY Kobayashi, J Lønborg, DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI Study Investigators
-
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary InterventionP Tricoci, LK Newby et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
